NEW YORK (GenomeWeb News) - Thomson Reuters said today that the National Cancer Institute will use the company’s BiomarkerCenter database to support its research on potential cancer therapeutics.
 
Thomson Reuters said that NCI’s Developmental Therapeutics program and its associated Biomarker Program will use BiomarkerCenter, a database of information on biomarkers that alerts uses to status changes of biomarkers of interest. The company launched the database in June.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.

Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.

China is embracing preimplantation genetic diagnosis, Nature News reports. 

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.